CD44, ACAN, PLVAP, and HBEGF Emerged as Potential Biomarkers in Diabetic Retinopathy

This study identified 4 genes (CD44, ACAN, PLVAP, and HBEGF) associated with DNA methylation may serve as biomarkers of DR, offering new insights into potential therapeutic strategies for DR.

Authors

Institutions

Publication Details

Journal
Diabetes Metabolic Syndrome and Obesity
Published
2025-10-01
DOI
https://doi.org/10.2147/dmso.s557119
Primary Topic
Advanced Glycation End Products research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CD44, ACAN, PLVAP, and HBEGF Emerged as Potential Biomarkers in Diabetic Retinopathy

Xiaorong Li, Juping Liu, Yi Peng, Yan Shao et al.
Diabetes Metabolic Syndrome and Obesity
Advanced Glycation End Products research
article

CD44, ACAN, PLVAP, and HBEGF Emerged as Potential Biomarkers in Diabetic Retinopathy

Xiaorong Li, Juping Liu, Yi Peng, Yan Shao, Ying Wang, Qingbo Li, Xu Zhou
article en

Abstract

This study identified 4 genes (CD44, ACAN, PLVAP, and HBEGF) associated with DNA methylation may serve as biomarkers of DR, offering new insights into potential therapeutic strategies for DR.

Diabetes Metabolic Syndrome and ObesityVol. Volume 18
Tianjin Medical University Eye Hospital (CN), Tibetan Traditional Medical College (CN), Tianjin Medical University (CN)
Openalex Percentile: Top 69%
Advanced Glycation End Products research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.